Arcturus Therapeutics
ARCT
#8407
Rank
โ‚ฌ0.18 B
Marketcap
6,55ย โ‚ฌ
Share price
6.53%
Change (1 day)
-62.43%
Change (1 year)

Earnings for Arcturus Therapeutics (ARCT)

Earnings in 2025 (TTM): -โ‚ฌ68.32 Million

According to Arcturus Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ85.14 Million. In 2024 the company made an earning of -โ‚ฌ78.8 Million a decrease over its 2023 earnings that were of -โ‚ฌ23.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arcturus Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ68.32 Million-13.3%
2024 -โ‚ฌ78.8 Million240.24%
2023 -โ‚ฌ23.16 Million-298.78%
2022 โ‚ฌ11.65 M-106.79%
2021 -โ‚ฌ0.18 Billion181.83%
2020 -โ‚ฌ60.9 Million183.72%
2019 -โ‚ฌ21.47 Million16.93%
2018 -โ‚ฌ18.36 Million154.5%
2017 -โ‚ฌ7.22 Million-65.36%
2016 -โ‚ฌ20.83 Million25.93%
2015 -โ‚ฌ16.54 Million-41.04%
2014 -โ‚ฌ28.05 Million219.64%
2013 -โ‚ฌ8.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NRC Health
NRC
โ‚ฌ23.54 M-136.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
-โ‚ฌ1.85 Million-97.12% Bahamas